No overview information available.
No background information available.
用于神经衰弱、神经衰弱综合征、血管神经性头痛、三叉神经痛、坐骨神经痛,眩晕症及高脂血症。可使这几种疾病的症状有不同程度的改善。
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
国药准字H20059025 | 注射剂 | N/A | 2ml:0.2g | Chemical Drug | Approved | 2020/11/17 | Domestic | ||
国药准字H20064512 | N/A | N/A | 2ml:0.2g | Chemical Drug | Approved | 2006/04/13 | Domestic | ||
国药准字H33022310 | 注射剂 | N/A | 2ml:0.2g | Chemical Drug | Approved | 2020/06/04 | Domestic | ||
国药准字H20058911 | 注射剂 | N/A | 2ml:0.2g | Chemical Drug | Approved | 2020/07/23 | Domestic | ||
国药准字H35021409 | 注射剂 | N/A | 2ml:0.2g | Chemical Drug | Approved | 2020/09/15 | Domestic | ||
国药准字H20064001 | 注射剂 | N/A | 2ml:0.2g | Chemical Drug | Approved | 2021/03/28 | Domestic | ||
国药准字H20083789 | 注射剂(小容量注射剂) | N/A | 5ml:0.6g | Chemical Drug | Approved | 2020/09/16 | Domestic | ||
国药准字H44021809 | 注射剂 | N/A | 2ml:200mg | Chemical Drug | Approved | 2020/03/17 | Domestic | ||
国药准字H20067058 | 注射剂 | N/A | 2ml:0.2g | Chemical Drug | Approved | 2016/08/09 | Domestic | ||
国药准字H11022401 | 注射剂(小容量注射剂) | N/A | 1ml:0.1g | Chemical Drug | Approved | 2021/07/23 | Domestic |
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|
No TGA products found for this drug